News

Experiencing an itchy scalp isn't just frustrating, it's also such an uncomfortable feeling. If you've ever had an itchy ...
Granuloma annulare causes a rash that’s easily mistaken for ringworm. This rash forms a clear circle with small, firm, ...
Dermatologists break down the most common circular rashes that aren’t ringworm, including hives, lupus, and atopic dermatitis ...
Patients with severe dystrophic epidermolysis bullosa, or EB, have skin so fragile, the slightest touch can lead to ...
Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can ...
In fact, for skin cancers on the head and neck, Mohs surgery has a remarkable 98-99% cure rate. This outpatient procedure is typically performed under local anesthesia, is cost-effective and ...
Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.
Persistence has paid off for Abeona Therapeutics and its gene therapy for recessive dystrophic epidermolysis bullosa (RDEB).
It is a progressively destructive infectious disease of the body tissue, affecting skin, muscle and even bone ... has gone 100 percent backwards," said Dr. Borna Nyaoke-Anoke, DNDi's head of mycetoma.